查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477108

神經調節市場，按技術、按應用、按生物材料、按國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Neuromodulation Market, By Technology, By Application, By Biomaterial, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 293 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年神經調節市場規模為 59.87 億美元，2024 年至 2032 年複合年成長率為 11.5%。

神經調節市場-市場動態

神經系統疾病盛行率上升推動市場需求

隨著神經系統問題變得越來越普遍，神經調節市場正在擴大。隨著年齡的成長，我們的身體開始失去抵抗感染和自我修復的能力，這使我們更容易患上一系列慢性疾病，如糖尿病、帕金森氏症、骨科困難、阿茲海默症和胃腸道問題。由於全球老年人口的增加，患有神經系統疾病的人數不斷增加。儘管如此，希臘、韓國、西班牙、葡萄牙、日本和西班牙等國家的老年人口比例要高得多；到2050 年，預計這些國家40% 的人口年齡將超過65 歲。 ：人口老化顯著增加，其特徵是神經系統疾病的高盛行率。這將有助於在整個預測期內擴大全球神經調節市場。

神經調節市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 11.5% 左右的複合年成長率成長

基於技術，內部神經調節領域預計在預測期內將以最高的複合年成長率成長

根據應用細分，帕金森氏症領域預計將在預測期內引領市場

按地區分類，北美是 2023 年的主要收入來源

神經調節市場-細分分析：

全球神經調節市場根據技術、應用、生物材料和地區進行細分。

根據技術，市場分為內部神經調節和外部神經調節。預計內部神經調節領域在預測期內將以最高的複合年成長率成長。患有慢性神經系統和疼痛疾病的患者可以透過使用內部神經調節療法（提供有針對性的可調節刺激）來顯著緩解症狀。隨著技術的進一步進步，這些療法的功效和應用預計將得到改善，從而推動內部神經調節領域的市場進一步擴張。

根據應用，該行業分為偏頭痛、慢性疼痛、腰背綜合症、大小便失禁、帕金森氏症、癲癇、顫抖、憂鬱症等。由於人口老化不斷加劇，預計帕金森氏症領域將在預測期內引領市場。

神經調節市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內主導市場。大型製藥和生物製藥行業，加上成熟的市場參與者的存在以及美國為採用尖端技術而不斷增加的投資，預計將推動該市場在該國的擴張。例如，根據帕金森氏症基金會2022年的最新資料，美國帕金森氏症（PD）的年診斷率預計約為9萬例，比先前預測的6萬例診斷率上升了50%。

神經調節市場-競爭格局：

該市場的主要參與者包括 Bioventus Inc.、Medtronic、Nevro Corporation、Neuronetics、MicroTransponder、NeuroPace Inc.、Boston Scientific Corporation、MicroTransponder、LivaNova PLC、Abbott 和 NeuroSigma。這些參與者採取了多種策略來獲取最大的市場佔有率，例如產品發布、收購、擴張等。

目錄

第 1 章：神經調節市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 神經調節市場技術片段
    • 按應用分類的神經調節市場片段
    • 生物材料的神經調節市場片段
    • 按國家/地區分類的神經調節市場片段
    • 按地區分類的神經調節市場片段
  • 競爭洞察

第 3 章：神經調節主要市場趨勢

  • 神經調節市場促進因素
    • 市場促進因素的影響分析
  • 神經調節市場限制
    • 市場限制影響分析
  • 神經調節市場機會
  • 神經調節市場未來趨勢

第 4 章：神經調節產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：神經調節市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：神經調節市場格局

  • 2023 年神經調節市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：神經調節市場 - 依技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 內部神經調節
    • 外部神經調節

第 8 章：神經調節市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 偏頭痛
    • 慢性疼痛
    • 失敗背部綜合症
    • 尿失禁和大便失禁
    • 帕金森綜合症
    • 癲癇
    • 震顫
    • 沮喪
    • 其他

第 9 章：神經調節市場 - 按生物材料

  • 概述
    • 按生物材料分類的細分市場佔有率分析
    • 高分子生物材料
    • 金屬生物材料
    • 陶瓷生物材料

第 10 章：神經調節市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美神經調節主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按應用）
    • 北美市場規模與預測（按生物材料）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲神經調節主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按生物材料）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區神經調節主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區生物材料市場規模及預測
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲神經調節主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按生物材料）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲神經調節主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按生物材料）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 神經調節產業

  • 競爭儀表板
  • 公司簡介
    • Bioventus Inc.
    • Medtronic
    • Nevro Corporation
    • Neuronetics
    • MicroTransponder
    • NeuroPace Inc
    • Boston Scientific Corporation
    • MicroTransponder
    • LivaNova PLC
    • Abbott
    • NeuroSigma

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究生物材料學
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2504

REPORT HIGHLIGHT

Neuromodulation Market size was valued at USD 5,987 Million in 2023, expanding at a CAGR of 11.5% from 2024 to 2032.

One technological advancement that directly affects nerves is neuromodulation. It is the change in nerve activity brought on by the direct application of medication or electricity to a specific location. The neuromodulation market uses state-of-the-art tools and therapies. They have an impact on every bodily system and are effective in treating almost all conditions, such as incontinence, tremors, migraines, and spinal cord injuries.

Neuromodulation Market- Market Dynamics

Increasing prevalence of neurological disorder to propel market demand

The neuromodulation market is expanding as neurological problems become more common. As we age, our bodies begin to lose their capacity to fight off infections and repair themselves, which leaves us more vulnerable to a host of chronic conditions like diabetes, Parkinson's disease, orthopedic difficulties, Alzheimer's disease, and gastrointestinal problems. There is an increasing number of people with neurological illnesses due to the global increase in the older population. Nonetheless, the percentage of the elderly population is much higher in nations like Greece, South Korea, Spain, Portugal, Japan, and Spain; by 2050, 40% of these nations' populations are predicted to be over 65. The number of people 65 years of age or older is expected to nearly treble globally by 2050. Therefore, the adoption of neuromodulation devices is projected to be driven by the notable increase in the ageing population, which is marked by a high prevalence of neurological illnesses. This will contribute to the expansion of the worldwide neuromodulation market throughout the forecast period.

Neuromodulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2024-2032)

Based on technology, the Internal Neuromodulation segment is expected to grow at the highest CAGR during the forecast period

Based on application segmentation, the Parkinson's Disease segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Neuromodulation Market- Segmentation Analysis:

The Global Neuromodulation Market is segmented based on Technology, Application, Biomaterial, and Region.

Based on the technology, the market is categorized into Internal Neuromodulation and External Neuromodulation. The Internal Neuromodulation segment is expected to grow at the highest CAGR during the forecast period. Patients with chronic neurological and pain diseases may find significant alleviation from their symptoms with the use of internal neuromodulation therapies, which give targeted and adjustable stimulation. The efficacy and application of these therapies are anticipated to improve with additional technological advancements, fueling further market expansion in the internal neuromodulation segment.

Based on the application, the industry is divided into Migraine, Chronic Pain, Failed Back Syndrome, Urinary And Fecal Incontinence, Parkinson's Disease, Epilepsy, Tremor, Depression and Others. The Parkinson's Disease segment is expected to lead the market over the projected period owing to the growing ageing population.

Neuromodulation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The large pharmaceutical and biopharmaceutical industries, together with the presence of well-established market players and growing investments in the United States for the adoption of cutting-edge technologies, are anticipated to drive the market's expansion in the nation. According to updated data from the Parkinson's Foundation in 2022, for example, the yearly diagnosis rate of Parkinson's disease (PD) in the United States is anticipated to be about 90,000, a 50% rise from the previous projection of 60,000 diagnoses.

Neuromodulation Market- Competitive Landscape:

The key players operating in the market include Bioventus Inc., Medtronic, Nevro Corporation, Neuronetics, MicroTransponder, NeuroPace Inc., Boston Scientific Corporation, MicroTransponder, LivaNova PLC, Abbott and NeuroSigma. These players adopted several strategies to capture the maximum market share such as product launch, acquisition, expansion and others.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bioventus Inc.

Medtronic

Nevro Corporation

Neuronetics

MicroTransponder

NeuroPace Inc

Boston Scientific Corporation

MicroTransponder

LivaNova PLC

Abbott

NeuroSigma

GLOBAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Internal Neuromodulation
  • External Neuromodulation

GLOBAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Migraine
  • Chronic Pain
  • Failed Back Syndrome
  • Urinary And Fecal Incontinence
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Others

GLOBAL NEUROMODULATION MARKET, BY BIOMATERIAL- MARKET ANALYSIS, 2019 - 2032

  • Polymeric Biomaterials
  • Metallic Biomaterials
  • Ceramic Biomaterials

GLOBAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Neuromodulation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Neuromodulation Market Snippet by Technology
    • 2.1.2.Neuromodulation Market Snippet by Application
    • 2.1.3.Neuromodulation Market Snippet by Biomaterial
    • 2.1.4.Neuromodulation Market Snippet by Country
    • 2.1.5.Neuromodulation Market Snippet by Region
  • 2.2.Competitive Insights

3.Neuromodulation Key Market Trends

  • 3.1.Neuromodulation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Neuromodulation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Neuromodulation Market Opportunities
  • 3.4.Neuromodulation Market Future Trends

4.Neuromodulation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Neuromodulation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Neuromodulation Market Landscape

  • 6.1.Neuromodulation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Neuromodulation Market - By Technology

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2.Internal Neuromodulation
    • 7.1.3.External Neuromodulation

8.Neuromodulation Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Migraine
    • 8.1.3.Chronic Pain
    • 8.1.4.Failed Back Syndrome
    • 8.1.5.Urinary And Fecal Incontinence
    • 8.1.6.Parkinson Disease
    • 8.1.7.Epilepsy
    • 8.1.8.Tremor
    • 8.1.9.Depression
    • 8.1.10.Others

9.Neuromodulation Market - By Biomaterial

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Biomaterial, 2023 & 2032 (%)
    • 9.1.2.Polymeric Biomaterials
    • 9.1.3.Metallic Biomaterials
    • 9.1.4.Ceramic Biomaterials

10.Neuromodulation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Neuromodulation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Neuromodulation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Neuromodulation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Neuromodulation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Neuromodulation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Neuromodulation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Bioventus Inc.
    • 11.2.2.Medtronic
    • 11.2.3.Nevro Corporation
    • 11.2.4.Neuronetics
    • 11.2.5.MicroTransponder
    • 11.2.6.NeuroPace Inc
    • 11.2.7.Boston Scientific Corporation
    • 11.2.8.MicroTransponder
    • 11.2.9.LivaNova PLC
    • 11.2.10.Abbott
    • 11.2.11.NeuroSigma

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Biomaterialology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Neuromodulation Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Neuromodulation Market, by Technology 2019-2032 (USD Million)
  • TABLE Neuromodulation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Neuromodulation Market, by Application 2019-2032 (USD Million)
  • TABLE Neuromodulation Market: BiomaterialSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Biomaterial
  • TABLE Global Neuromodulation Market, by Biomaterial2019-2032 (USD Million)
  • TABLE Neuromodulation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Neuromodulation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)